247 related articles for article (PubMed ID: 15791891)
1. Treatment of cholesterol abnormalities.
Lockman AR; Tribastone AD; Knight KV; Franko JP
Am Fam Physician; 2005 Mar; 71(6):1137-42. PubMed ID: 15791891
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of Atorvastatin-induced very low-density lipoprotein cholesterol levels in Patients with coronary heart disease (a post hoc analysis of the treating to new targets [TNT] study).
LaRosa JC; Grundy SM; Kastelein JJ; Kostis JB; Greten H;
Am J Cardiol; 2007 Sep; 100(5):747-52. PubMed ID: 17719314
[TBL] [Abstract][Full Text] [Related]
3. [Hypercholesterolemia and coronary disease: intervention strategies].
Brunelli C; Spallarossa P; Saccani A; Corsiglia L; Ghigliotti G; Caponnetto S
Cardiologia; 1991 Dec; 36(12 Suppl 1):303-8. PubMed ID: 1841785
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic intervention for hypercholesterolemia.
Gotto AM
Clin Cardiol; 1992 Nov; 15(11):III18-21; discussion III22-4. PubMed ID: 1458692
[TBL] [Abstract][Full Text] [Related]
5. The benefit of cholesterol-lowering medications after coronary revascularization: a population study.
Brophy JM; Brassard P; Bourgault C
Am Heart J; 2005 Aug; 150(2):282-6. PubMed ID: 16086931
[TBL] [Abstract][Full Text] [Related]
6. Should all patients with cardiovascular disease receive statin therapy?
Vogel R; Schaefer E
Am J Manag Care; 2001 May; 7(5 Suppl):S117-24. PubMed ID: 11383372
[TBL] [Abstract][Full Text] [Related]
7. Cholesterol reduction in patients with lower limb atherosclerotic disease.
Bismuth J; Kofoed SC; Sillesen HH
Dan Med Bull; 2002 Feb; 49(1):61-4. PubMed ID: 11894724
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of pravastatin in primary prevention of cardiovascular events in women: analysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA study).
Mizuno K; Nakaya N; Ohashi Y; Tajima N; Kushiro T; Teramoto T; Uchiyama S; Nakamura H;
Circulation; 2008 Jan; 117(4):494-502. PubMed ID: 18172039
[TBL] [Abstract][Full Text] [Related]
9. [Hypercholesterolemia as cardiovascular risk in hypertensive patients. Therapeutic implications: efficiency of statins].
Borghi C; Veronesi M
Recenti Prog Med; 2003 Oct; 94(10):421-6. PubMed ID: 14619187
[TBL] [Abstract][Full Text] [Related]
10. [Prevention of cardiovascular complications after a stroke or TIA: hypotensive and hypocholesterolemic therapy].
Dippel DW; van der Worp HB
Ned Tijdschr Geneeskd; 2004 Apr; 148(17):820-4. PubMed ID: 15141647
[TBL] [Abstract][Full Text] [Related]
11. [Reducing cholesterol in cardiovascular rehabilitation--exercise versus drug therapy].
Halle M; Berg A; Keul J
Wien Klin Wochenschr; 1997; 109 Suppl 2():29-32. PubMed ID: 9340920
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of ezetimibe added on to atorvastatin (20 mg) versus uptitration of atorvastatin (to 40 mg) in hypercholesterolemic patients at moderately high risk for coronary heart disease.
Conard SE; Bays HE; Leiter LA; Bird SR; Rubino J; Lowe RS; Tomassini JE; Tershakovec AM
Am J Cardiol; 2008 Dec; 102(11):1489-94. PubMed ID: 19026302
[TBL] [Abstract][Full Text] [Related]
13. [Stanols--a new perspective in treatment of hypercholesterolemia?].
Jankowski P; Bilo G; Bryniarski L; Bryniarska-Mirek E; Pajak A
Przegl Lek; 2000; 57(11):655-8. PubMed ID: 11293214
[TBL] [Abstract][Full Text] [Related]
14. [New results in the management of hypercholesterolemia].
Sármán B
Orv Hetil; 2005 Sep; 146(39):1999-2004. PubMed ID: 16265867
[TBL] [Abstract][Full Text] [Related]
15. [Cholesterol and stroke risk: a role for statins?].
Devuyst G; Bogousslavsky J
Schweiz Med Wochenschr; 2000 Aug; 130(33):1157-63. PubMed ID: 11005106
[TBL] [Abstract][Full Text] [Related]
16. Risk of myocardial infarction attributable to elevated levels of total cholesterol among hypertensives.
Glazer NL; Smith NL; Heckbert SR; Doggen CJ; Lemaitre RN; Psaty BM
Am J Hypertens; 2005 Jun; 18(6):759-66. PubMed ID: 15925732
[TBL] [Abstract][Full Text] [Related]
17. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.
Abdel-Maksoud M; Sazonov V; Gutkin SW; Hokanson JE
J Cardiovasc Pharmacol; 2008 Apr; 51(4):331-51. PubMed ID: 18427276
[TBL] [Abstract][Full Text] [Related]
18. Cholesterol-lowering nutraceuticals and functional foods.
Chen ZY; Jiao R; Ma KY
J Agric Food Chem; 2008 Oct; 56(19):8761-73. PubMed ID: 18778072
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic management of isolated low high-density lipoprotein syndrome.
Bermúdez V; Cano R; Cano C; Bermúdez F; Arraiz N; Acosta L; Finol F; Pabón MR; Amell A; Reyna N; Hidalgo J; Kendall P; Manuel V; Hernández R
Am J Ther; 2008; 15(4):377-88. PubMed ID: 18645343
[TBL] [Abstract][Full Text] [Related]
20. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.
Hennekens CH; Schneider WR
Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
